Université de Strasbourg, Inserm, Institut de Recherche sur les Maladies Virales et Hépatiques UMR_S1110, 67000 Strasbourg, France.
Institut Hospitalo-Universitaire, Pôle Hépato-Digestif, Nouvel Hôpital Civil, 1 Place de L'Hôpital, 67000 Strasbourg, France.
Viruses. 2021 Aug 3;13(8):1532. doi: 10.3390/v13081532.
Chronic hepatitis D is one of the most severe and aggressive forms of chronic viral hepatitis with a high risk of developing hepatocellular carcinoma (HCC). It results from the co-infection of the liver with the hepatitis B virus (HBV) and its satellite, the hepatitis D virus (HDV). Although current therapies can control HBV infection, no treatment that efficiently eliminates HDV is available and novel therapeutic strategies are needed. Although the HDV cycle is well described, the lack of simple experimental models has restricted the study of host-virus interactions, even if they represent relevant therapeutic targets. In the last few years, the discovery of the sodium taurocholate co-transporting polypeptide (NTCP) as a key cellular entry factor for HBV and HDV has allowed the development of new cell culture models susceptible to HBV and HDV infection. In this review, we summarize the main in vitro model systems used for the study of HDV entry and infection, discuss their benefits and limitations and highlight perspectives for future developments.
慢性丁型肝炎是最严重和侵袭性的慢性病毒性肝炎之一,其肝细胞癌(HCC)的发生风险较高。它是由乙型肝炎病毒(HBV)及其卫星乙型肝炎病毒(HDV)共同感染肝脏引起的。尽管目前的治疗方法可以控制 HBV 感染,但尚无有效的清除 HDV 的治疗方法,因此需要新的治疗策略。尽管 HDV 周期已经得到很好的描述,但缺乏简单的实验模型限制了宿主-病毒相互作用的研究,即使它们是相关的治疗靶点。在过去的几年中,发现牛磺胆酸钠共转运多肽(NTCP)是 HBV 和 HDV 的关键细胞进入因子,这使得开发对 HBV 和 HDV 感染敏感的新细胞培养模型成为可能。在这篇综述中,我们总结了用于研究 HDV 进入和感染的主要体外模型系统,讨论了它们的优缺点,并强调了未来发展的前景。